Xcout IntelMyomo Inc.
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Subscribe to see Myomo Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Myomo Inc. at a glance
Myomo Inc. is a medical - devices company headquartered in Burlington, United States. It is publicly listed (MYO) with a market capitalisation of $57.4M. Xcout tracks 20 named people at Myomo Inc., including Paul R. Gudonis (President, Chief Executive Officer & Chairman).
Myomo Inc. leadership
- Paul R. GudonisPresident, Chief Executive Officer & Chairman
- David A. HenryChief Financial Officer
- David HenryChief Financial Officer
- Harry KovelmanChief Medical Officer
- Micah J. MitchellChief Commercial Officer
- Dr. Harry KovelmanChief Medical Officer
14 more named people on record for Myomo Inc., with roles, board committees and tenure — see the full roster →
Myomo Inc. funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $620,000 | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Myomo Inc. competitors
A few of Myomo Inc.'s closest competitors — see the full list of competitors and alternatives →
OnTrack Rehabilitation develops a smart arm rehabilitation system designed to help stroke survivors track arm movement and stay motivated during recovery. The device uses smart sensors to monitor daily movement and provides evidence-based coaching to support self-management and rehabilitation needs.
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0. Founded by Amit Goffer on June 20, 2001, the enterprise maintains its corporate headquarters in Marlborough, Massachusetts.
Delsys, Inc. is a biotechnology research company specializing in the development and manufacturing of advanced electromyography (EMG) sensors and kinesiological measurement systems. The public/private enterprise is headquartered in Natick, Massachusetts.
Osteoboost Health is a medical equipment manufacturing company headquartered in San Francisco, California, that produces the first FDA-cleared non-pharmacological wearable vibration therapy designed to reduce bone loss in women with osteopenia.
Lifespark Technologies is a healthcare technology company headquartered in Mumbai, India, that builds innovative digital solutions and assistive devices for neurological conditions such as Parkinson's Disease and stroke.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Get Myomo Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Myomo Inc. in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 1 funding round before the IPO with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access